Sibeprenlimab-szsi (Voyxact)
To reduce proteinuria in primary immunoglobulin A nephropathy in adults at risk for disease progression
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
To reduce proteinuria in primary immunoglobulin A nephropathy in adults at risk for disease progression